The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 38 results:
Author Title Type [ Year(Asc)]
Filters: Author is Iosifidis, Elias  [Clear All Filters]
2020
Karampatakis, T., Tsergouli K., Iosifidis E., Antachopoulos C., Mouloudi E., Karyoti A., et al. (2020).  Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area.. J Glob Antimicrob Resist. 20, 214-218.
Antoniadi, K., Iosifidis E., Vasileiou E., Tsipou C., Lialias I., Papakonstantinou E., et al. (2020).  Invasive Mucormycosis in Children With Malignancies. Journal of Pediatric Hematology/Oncology. Publish Ahead of Print,
Antoniadi, K., Iosifidis E., Vasileiou E., Tsipou C., Lialias I., Papakonstantinou E., et al. (2020).  Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.. J Pediatr Hematol Oncol.
Papachristou, S. G., Iosifidis E., Sipsas N. V., Gamaletsou M. N., Walsh T. J., & Roilides E. (2020).  Management of osteoarticular fungal infections in the setting of immunodeficiency.. Expert Rev Anti Infect Ther. 18(5), 461-474.
Lutsar, I., Chazallon C., Trafojer U., de Cabre V. Meiffredy, Auriti C., Bertaina C., et al. (2020).  Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.. PLoS One. 15(3), e0229380.
Li, G., Bielicki J. Anna, Ahmed A. S. M. Nawsha, Islam M. Shahidul, Berezin E. Naaman, Gallacci C. B., et al. (2020).  Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network.. Arch Dis Child. 105(1), 26-31.
2019
Karampatakis, T., Tsergouli K., Iosifidis E., Antachopoulos C., Volakli E., Karyoti A., et al. (2019).  Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care.. Microb Drug Resist. 25(9), 1347-1356.
Tsekoura, M., Ioannidou M., Pana Z-D., Haidich A-B., Antachopoulos C., Iosifidis E., et al. (2019).  Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.. Pediatr Infect Dis J. 38(1), 42-49.
Papachristou, S., Iosifidis E., & Roilides E. (2019).  Invasive Aspergillosis in Pediatric Leukemia Patients: Prevention and Treatment.. J Fungi (Basel). 5(1), 
Karampatakis, T., Tsergouli K., Politi L., Diamantopoulou G., Iosifidis E., Antachopoulos C., et al. (2019).  Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit.. Microb Drug Resist. 25(5), 712-716.
Karampatakis, T., Tsergouli K., Politi L., Diamantopoulou G., Iosifidis E., Antachopoulos C., et al. (2019).  Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit.. Mol Biol Rep. 46(3), 3497-3500.
Darda, V. Magdalini, Iosifidis E., Antachopoulos C., Volakli E., Haidich A. Bettina, Vagdatli E., et al. (2019).  Risk factors for carbapenem resistance and outcomes when treating bloodstream infections in a paediatric intensive care unit.. Acta Paediatr. 108(10), 1923-1924.
Roilides, I., Vasilaki K., Xinias I., Iosifidis E., Antachopoulos C., & Roilides E. (2019).  Thiamine Deficiency in a Child with Short Bowel Syndrome and Review.. Pediatr Gastroenterol Hepatol Nutr. 22(5), 493-499.
Iosifidis, E., Chorafa E., Agakidou E., Kontou A., Violaki A., Volakli E., et al. (2019).  Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of Age.. Pediatr Infect Dis J. 38(8), 812-815.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.